JP2022526014A5 - - Google Patents
Info
- Publication number
- JP2022526014A5 JP2022526014A5 JP2021559817A JP2021559817A JP2022526014A5 JP 2022526014 A5 JP2022526014 A5 JP 2022526014A5 JP 2021559817 A JP2021559817 A JP 2021559817A JP 2021559817 A JP2021559817 A JP 2021559817A JP 2022526014 A5 JP2022526014 A5 JP 2022526014A5
- Authority
- JP
- Japan
- Prior art keywords
- appears
- following structure
- independently
- bond
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024216317A JP2025039569A (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832723P | 2019-04-11 | 2019-04-11 | |
| US62/832,723 | 2019-04-11 | ||
| US201962877144P | 2019-07-22 | 2019-07-22 | |
| US62/877,144 | 2019-07-22 | ||
| PCT/US2020/027750 WO2020210689A1 (en) | 2019-04-11 | 2020-04-10 | Programmable polymeric drugs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024216317A Division JP2025039569A (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526014A JP2022526014A (ja) | 2022-05-20 |
| JP2022526014A5 true JP2022526014A5 (https=) | 2024-07-11 |
| JP7603918B2 JP7603918B2 (ja) | 2024-12-23 |
Family
ID=70476549
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559817A Active JP7603918B2 (ja) | 2019-04-11 | 2020-04-10 | プログラム可能なポリマー薬 |
| JP2024216317A Pending JP2025039569A (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024216317A Pending JP2025039569A (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220160887A1 (https=) |
| EP (1) | EP3952916A1 (https=) |
| JP (2) | JP7603918B2 (https=) |
| KR (1) | KR20210152523A (https=) |
| CN (1) | CN114430738A (https=) |
| WO (1) | WO2020210689A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| KR102646956B1 (ko) | 2015-02-26 | 2024-03-14 | 소니그룹주식회사 | 페닐에티닐나프탈렌 염료 및 이의 사용 방법 |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN107709470B (zh) | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| CN109415574B (zh) | 2016-04-01 | 2021-05-28 | 索尼公司 | 具有刚性间隔基团的超亮二聚体或聚合物染料 |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| CN117750977A (zh) * | 2021-07-22 | 2024-03-22 | 索尼集团公司 | 聚合型药物的自动合成 |
| WO2023002431A1 (en) * | 2021-07-22 | 2023-01-26 | Sony Group Corporation | Automated synthesis of polymeric drugs |
| CN119997980A (zh) * | 2022-09-22 | 2025-05-13 | 索尼集团公司 | 具有类固醇或维生素的聚合物 |
| EP4598940A1 (en) | 2022-10-04 | 2025-08-13 | Eli Lilly and Company | Gene therapy for trem2-associated diseases and disorders |
| AU2023375569A1 (en) | 2022-11-11 | 2025-05-29 | Eli Lilly And Company | Synthetic nucleic acids including astrocyte-directed promoter constructs and methods of using the same |
| WO2026043765A1 (en) | 2024-08-21 | 2026-02-26 | Eli Lilly And Company | Engineered regulatory splice elements for gene therapies |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545447B2 (en) * | 2013-01-04 | 2017-01-17 | The Texas A&M University System | Polymer-drug systems |
| EP3019559A4 (en) * | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| US11827661B2 (en) * | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN107709470B (zh) * | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| JP6817288B2 (ja) * | 2015-08-10 | 2021-01-20 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 |
| AU2017240154B2 (en) * | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| CN109415574B (zh) * | 2016-04-01 | 2021-05-28 | 索尼公司 | 具有刚性间隔基团的超亮二聚体或聚合物染料 |
| WO2017177065A2 (en) * | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| EP3455299B1 (en) * | 2016-05-10 | 2024-01-17 | Sony Group Corporation | Compositions comprising a polymeric dye and a cyclodextrin and uses thereof |
| EP3455300A1 (en) * | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) * | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| KR20260011205A (ko) * | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| WO2019071153A1 (en) * | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| CN111836645A (zh) * | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| EP3737417B1 (en) * | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| CN111565756A (zh) * | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| KR102742386B1 (ko) * | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) * | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| JP7580689B2 (ja) * | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| WO2021062176A2 (en) * | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
-
2020
- 2020-04-10 EP EP20722939.4A patent/EP3952916A1/en active Pending
- 2020-04-10 KR KR1020217036843A patent/KR20210152523A/ko active Pending
- 2020-04-10 WO PCT/US2020/027750 patent/WO2020210689A1/en not_active Ceased
- 2020-04-10 JP JP2021559817A patent/JP7603918B2/ja active Active
- 2020-04-10 US US17/602,689 patent/US20220160887A1/en active Pending
- 2020-04-10 CN CN202080040293.XA patent/CN114430738A/zh active Pending
-
2024
- 2024-12-11 JP JP2024216317A patent/JP2025039569A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526014A5 (https=) | ||
| JP2022526651A5 (https=) | ||
| JP2022526017A5 (https=) | ||
| US20200247887A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
| CN102580084B (zh) | Her抗体的固定剂量给药 | |
| EP3952917A1 (en) | Programmable polymeric drugs | |
| WO2020210689A1 (en) | Programmable polymeric drugs | |
| US7378091B2 (en) | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen | |
| CN120037399A (zh) | 可编程的聚合药物 | |
| JP2024536224A5 (https=) | ||
| JP2024537069A5 (https=) | ||
| JP2018161141A (ja) | ヘテロ多量体分子を作製するための方法 | |
| IL287292B (en) | and fusion antibody-drug-cd79b engineered antibodies cysteine- | |
| JP2008523073A (ja) | Ｈｅｒ阻害剤を用いた治療のための患者の選択 | |
| JP2008523083A (ja) | 炎症性疾患および免疫調節不全疾患、感染性疾患、病的血管新生およびがんの免疫療法および検出のための方法および組成物 | |
| NZ583318A (en) | Humanized anti-cd79b antibodies and immunoconjugates and methods of use | |
| US20250009786A1 (en) | Automated synthesis of polymeric dual drugs | |
| US20240307548A1 (en) | Enhanced targeting using antibody-oligonucleotide conjugates | |
| JP2024532726A5 (https=) | ||
| WO2023052970A1 (en) | Pyrrolobenzodiazepine conjugates for cancer treatment | |
| EP3762037B1 (en) | Releasable antibody conjugates | |
| EP4622675A1 (en) | Polymeric compounds comprising antineoplastic agents | |
| TW202517255A (zh) | 化合物、組合物及方法 | |
| TW202504641A (zh) | 用於淋巴瘤之診斷及治療方法的巨噬細胞特徵 | |
| WO2024062319A1 (en) | Polymers with dual therapeutic agents |